InvestorsHub Logo
Followers 834
Posts 119891
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Friday, 06/25/2021 9:43:01 AM

Friday, June 25, 2021 9:43:01 AM

Post# of 754
Rinvoq FDA review in PA delayed (again) due to JAK-class safety issues:

https://finance.yahoo.com/news/abbvie-provides-regarding-rinvoq-upadacitinib-123000377.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News